TCM
ABBV icon

Tuttle Capital Management’s AbbVie ABBV Stock Holding History

Tuttle Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,829
Closed -$631K – 264
2021
Q1 		$631K Buy
+5,829
New +$623K 0.25% 101
2020
Q4 		– Sell
-18,926
Closed -$1.66M – 175
2020
Q3 		$1.66M Buy
18,926
+5,760
+44% +$542K 1.14% 12
2020
Q2 		$1.29M Buy
+13,166
New +$1.16M 0.92% 35
2020
Q1 		– Sell
-17,642
Closed -$1.56M – 69
2019
Q4 		$1.56M Buy
+17,642
New +$1.46M 0.59% 37

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Tuttle Capital Management's ABBV Position: Q2 2021 in Review

Tuttle Capital Management sold out of AbbVie (ABBV) in Q2 2021, closing a stake of 5,829 shares — an estimated $631K sold.

Tuttle Capital Management first reported a position in ABBV in Q4 2019 and held it in 4 quarters. The position peaked at $1.66M in Q3 2020. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

  • Tuttle Capital Management reported no remaining AbbVie position as of Q2 2021 after selling out during the quarter.
  • Tuttle Capital Management sold 5,829 AbbVie shares in Q2 2021, an estimated $631K.
  • Tuttle Capital Management first reported a position in AbbVie in Q4 2019 and held it in 4 quarters.
  • Tuttle Capital Management's AbbVie position peaked at $1.66M in Q3 2020.
  • 2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Tuttle Capital Management's 13F filing for Q2 2021, filed 21 Jul 2021.